Skip to main content
Toggle navigation
Login
Search
Home
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Browse by Speaker
Browse by Speaker
Type here to filter the list
All
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
S
Saini, Sidharth
Toronto General Hospital
Paper 35 - DETECTION OF SATELLITE TUMOUR CELLS IN PERI-TUMORAL EDEMA IN INFILTRATIVE SOFT TISSUE SARCOMAS USING A TARGETED MOLECULAR APPROACH
Sidharth Saini
Favorite
Salazar Arcila, Carolina
University of Calgary
Paper 56 - STING ACTIVATION AS AN IMMUNOGENIC THERAPY FOR UNDIFFERENTIATED PLEOMORPHIC SARCOMA
Carolina Salazar Arcila
Favorite
Sanchez Esquer, Ignacio
Hospital Universitario Virgen de la Arrixaca
Paper 68 - CHARACTERISTICS, APPLICATIONS, UTILITY AND USABILITY OF 3D MODELS IN HIGH COMPLEXITY SURGICAL ONCOLOGY. A READY-TO-USE TECHNOLOGY.
Ignacio Sanchez Esquer
Favorite
Sandven, Ingunn
Oslo University Hospital
Paper 53 - THERE’S NO PLACE LIKE HOME. TREATING ADOLESCENTS AND YOUNG ADULTS WITH SARCOMA AT HOME
Ingunn Sandven
Favorite
Sanfilippo, Roberta
Fondazione IRCCS Istituto Nazionale dei Tumori
Paper 63 - DO EARLY RECURRENT PRIMARY RETROPERITONEAL SARCOMA (RPS) HAVE SIMILAR SURVIVAL TO INOPERABLE RPS: WAS SURGERY WORTHY?
Roberta Sanfilippo
Favorite
Paper 65 - IDENTIFICATION OF A GENOMIC SIGNATURE THAT IMPROVES THE PERFORMANCE OF THE SARCULATOR NOMOGRAM FOR PATIENTS WITH PRIMARY RETROPERITONEAL SARCOMA
Roberta Sanfilippo
Favorite
Paper 66 - LONG TERM FOLLOW-UP OF MTOR INHIBITORS AND EXEMESTANE TREATMENT IN PRECOMA PATIENTS PROGRESSING TO MTOR INHIBITORS ALONE. RESULTS FROM TWO EUROPEAN REFERRAL CENTERS
Roberta Sanfilippo
Favorite
Sangalli, Claudia
Fondazione IRCCS Istituto Nazionale dei Tumori
Paper 63 - DO EARLY RECURRENT PRIMARY RETROPERITONEAL SARCOMA (RPS) HAVE SIMILAR SURVIVAL TO INOPERABLE RPS: WAS SURGERY WORTHY?
Claudia Sangalli
Favorite
Saraf, Amanda
Riley Children's Hospital
Paper 14 - TUMOR-TUMOR COOPERATION DURING OSTEOSARCOMA LUNG METASTASIS IS DRIVEN BY EPITHELIAL INTERACTIONS WITH NICHE-INITIATING ANCHOR CELLS
Amanda Saraf
Favorite
Sarre, Catherine
TARPSWG
Paper 01 - CREATION AND IMPLEMENTATION OF A MONTHLY INTERNATIONAL TUMOR BOARD: EXPERIENCE OF THE TRANSATLANTIC AUSTRALASIAN RETROPERITONEAL SARCOMA WORKING GROUP (TARPSWG)
Catherine Sarre
Favorite
Satcher, Robert
University of Texas MD Anderson Cancer Center
Paper 76 - PRACTICE PATTERNS IN THE MANAGEMENT OF REGIONAL LYMPH NODE METASTASIS IN SOFT TISSUE SARCOMA: A SURVEY OF THE SOCIETY OF SURGICAL ONCOLOGY AND MUSCULOSKELETAL TUMOR SOCIETY MEMBERSHIP
Robert Satcher
Favorite
Savjani, Ricky
University of California, Los Angeles
Paper 72 - SURGICAL OUTCOMES IN PATIENTS TREATED WITH 5-DAY PREOPERATIVE RADIOTHERAPY FOR PRIMARY SOFT TISSUE SARCOMA
Ricky Savjani
Favorite
Sayyed, Raza
The Royal Marsden Hospital
Paper 01 - CREATION AND IMPLEMENTATION OF A MONTHLY INTERNATIONAL TUMOR BOARD: EXPERIENCE OF THE TRANSATLANTIC AUSTRALASIAN RETROPERITONEAL SARCOMA WORKING GROUP (TARPSWG)
Raza Sayyed
Favorite
Sayyed, Raza
The Royal Marsden Hospital NHS Foundation Trust
Paper 64 - PRIMARY RETROPERITONEAL SARCOMA: VARIABILITY OF RESECTABILITY AND TREATMENT ALLOCATION DURING MULTIDISCIPLINARY TEAM MEETING ASSESSMENTS IN ENGLAND
Raza Sayyed
Favorite
Sayyed, Raza
The Royal Marsden Hospital
Paper 86 - POST-IRRADIATION SARCOMAS: INCREASE IN REFERRALS AND IMPROVED SURVIVAL AT AN EXPERT SARCOMA REFERRAL CENTRE OVER THREE DECADES
Raza Sayyed
Favorite
Scally, Christopher
University of Texas MD Anderson Cancer Center
Paper 76 - PRACTICE PATTERNS IN THE MANAGEMENT OF REGIONAL LYMPH NODE METASTASIS IN SOFT TISSUE SARCOMA: A SURVEY OF THE SOCIETY OF SURGICAL ONCOLOGY AND MUSCULOSKELETAL TUMOR SOCIETY MEMBERSHIP
Christopher Scally
Favorite
Schaefer, Inga-Marie
Brigham and Women's Hospital
Diagnostic Advances: Poster Highlights
Inga-Marie Schaefer
Favorite
Liddy Shriver Early Research Award
Location: VCC, East Exhibition Hall A
Inga-Marie Schaefer
Favorite
Scharschmidt, Thomas
Ohio State University Wexner Medical Center
Paper 48 - INTRA-ARTICULAR INJECTIONS OF AMB-05X, A POTENT, SELECTIVE, HUMAN MONOCLONAL ANTIBODY AGAINST COLONY STIMULATING FACTOR 1 RECEPTOR FOR THE TREATMENT OF TENOSYNOVIAL GIANT CELL TUMOR
Thomas Scharschmidt
Favorite
Schneider, Patricia
McMaster University
Paper 73 - RISK FACTORS FOR ALL-CAUSE EARLY RE-OPERATIONS IN PATIENTS UNDERGOING TUMOR RESECTION AND ENDOPROSTHETIC RECONSTRUCTION: A SECONDARY ANALYSIS FROM THE PARITY TRIAL
Patricia Schneider
Favorite
Schöffski, Patrick
Laboratory of Experimental Oncology, Department of Oncology, KU Leuven, Leuven Cancer Institute
Paper 19 - A PHASE IA/IB, DOSE-ESCALATION/EXPANSION STUDY OF THE MDM2–P53 ANTAGONIST BI 907828 IN PATIENTS WITH SOLID TUMORS, INCLUDING ADVANCED/METASTATIC LIPOSARCOMA
Patrick Schöffski
Favorite
Paper 46 - ANTI-TUMOR EFFECTS OF THE NOVEL KIT MUTANT INHIBITOR M4205/IDRX-42 IN GASTROINTESTINAL STROMAL TUMOR (GIST) XENOGRAFT MODELS
Patrick Schöffski
Favorite
Paper 80 - DEFI: A PHASE 3, RANDOMIZED, DOUBLE-BLIND TRIAL OF NIROGACESTAT VERSUS PLACEBO FOR PROGRESSING DESMOID TUMORS/AGGRESSIVE FIBROMATOSIS
Patrick Schöffski
Favorite
Schoot, R.A.
Princess Máxima Center for Pediatric Oncology
Paper 33 - ASSESSING THE ROLE OF DIFFUSION-WEIGHTED MR IMAGING IN PEDIATRIC AND ADOLESCENT RHABDOMYOSARCOMA: AN INTERNATIONAL RETROSPECTIVE STUDY ON BEHALF OF THE EPSSG IMAGING COMMITTEE
R.A. Schoot
Favorite
Schrage, Yvonne
Netherland Cancer Institute
Paper 71 - SUBTYPE-RELATED RESPONSE TO ISOLATED LIMB PERFUSION IN SOFT TISSUE SARCOMAS
Yvonne Schrage
Favorite
Schuetze, Scott
University of Michigan
Paper 18 - PHASE II MULTI-CENTER TRIAL OF TRABECTEDIN IN COMBINATION WITH OLAPARIB IN ADVANCED UNRESECTABLE OR METASTATIC SARCOMA
Scott Schuetze
Favorite
Paper 22 - P10015/SARC033: A PHASE 2 TRIAL OF TRAMETINIB IN PATIENTS WITH ADVANCED EPITHELIOID HEMANGIOENDOTHELIOMA
Scott Schuetze
Favorite
Paper 61 - FINAL ANALYSIS FROM SPEARHEAD-1 COHORT 1 OF AFAMITRESGENE AUTOLEUCEL (“AFAMI-CEL” [FORMERLY ADP-A2M4]) IN ADVANCED SYNOVIAL SARCOMA AND MYXOID/ROUND CELL LIPOSARCOMA
Scott Schuetze
Favorite
Schut, Anne-Rose
Erasmus Medical Center Rotterdam
Paper 77 - ACTIVE SURVEILLANCE IN PATIENTS WITH DESMOID-TYPE FIBROMATOSIS: A COMBINED ANALYSIS OF TWO PROSPECTIVE OBSERVATIONAL STUDIES
Anne-Rose Schut
Favorite
Schwartz, Gary
Columbia University Herbert Irving Comprehensive Cancer Center
Paper 17 - A PHASE 1B STUDY OF UNESBULIN (PTC596) PLUS DACARBAZINE FOR THE TREATMENT OF PATIENTS WITH ADVANCED LEIOMYOSARCOMA
Gary Schwartz
Favorite
Paper 22 - P10015/SARC033: A PHASE 2 TRIAL OF TRAMETINIB IN PATIENTS WITH ADVANCED EPITHELIOID HEMANGIOENDOTHELIOMA
Gary Schwartz
Favorite
Paper 58 - A PHASE IA/IB STUDY OF BOTENSILIMAB, A NOVEL INNATE/ADAPTIVE IMMUNE ACTIVATOR, PLUS BALSTILIMAB FOR THE TREATMENT OF PATIENTS WITH SARCOMA
Gary Schwartz
Favorite
Sciot, Raf
Department of Pathology, KU Leuven and University Hospitals Leuven
Paper 46 - ANTI-TUMOR EFFECTS OF THE NOVEL KIT MUTANT INHIBITOR M4205/IDRX-42 IN GASTROINTESTINAL STROMAL TUMOR (GIST) XENOGRAFT MODELS
Raf Sciot
Favorite
Scott, Jacob
Cleveland Clinic
Paper 02 - NATIONAL EWING SARCOMA (NEWS) TUMOR BOARD: MONTHLY MULTI-INSTITUTIONAL, MULTIDISCIPLINARY VIRTUAL TUMOR BOARD FOR EWING SARCOMA, SUMMARY OF THE FIRST YEAR
Jacob Scott
Favorite
Selich-Anderson, Julia
Abigail Wexner Research Institute at Nationwide Children's Hospital
Paper 95 - STUDYING THE ROLE OF FLI PORTION OF EWS: FLI IN TRANSCRIPTION REGULATION VIA MODULATION OF CHROMATIN 3D LANDSCAPE IN EWING SARCOMA
Julia Selich-Anderson
Favorite
Serrano, César
Vall D'hebron Institute of Oncology
Paper 36 - INCREASED PROGRESSION FREE SURVIVAL (PFS) IN ADVANCED GASTROINTESTINAL STROMAL TUMOR (GIST) PATIENTS TREATED WITH SUNITINIB AFTER CIRCULATING TUMOR DNA DETECTION OF A KIT EXON 13 RESISTANCE MUTATION
César Serrano
Favorite
Serrano, Jonathan
Department of Pathology, New York University Langone Health, Perlutter Cancer Center
Paper 07 - CLINICAL AND GENOMIC PROGNOSTIC FACTORS IN MALIGNANT PERIPHERAL NERVE SHEATH TUMORS: INSIGHTS GAINED THROUGH THE GENOMICS OF MPNST CONSORTIUM
Jonathan Serrano
Favorite
Servois, Vincent
Institut Curie - Paris, FRANCE
Paper 34 - PERCUTANEOUS UTERINE NEEDLE BIOPSY WITH MICROSCOPIC AND ARRAY-CGH ANALYSES IN PATIENTS WITH SUSPICIOUS MYOMETRIAL TUMORS ON MRI: A PROSPECTIVE STUDY
Vincent Servois
Favorite
Setty, Bhuvana
Nationwide Children's Hospital
Paper 02 - NATIONAL EWING SARCOMA (NEWS) TUMOR BOARD: MONTHLY MULTI-INSTITUTIONAL, MULTIDISCIPLINARY VIRTUAL TUMOR BOARD FOR EWING SARCOMA, SUMMARY OF THE FIRST YEAR
Bhuvana Setty
Favorite
Shankar, Arjun
University College London Hospitals NHS Foundation Trust
Paper 64 - PRIMARY RETROPERITONEAL SARCOMA: VARIABILITY OF RESECTABILITY AND TREATMENT ALLOCATION DURING MULTIDISCIPLINARY TEAM MEETING ASSESSMENTS IN ENGLAND
Arjun Shankar
Favorite
Shepard, Dale
Cleveland Clinic Taussig Cancer Institute
Paper 22 - P10015/SARC033: A PHASE 2 TRIAL OF TRAMETINIB IN PATIENTS WITH ADVANCED EPITHELIOID HEMANGIOENDOTHELIOMA
Dale Shepard
Favorite
Shern, John
Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute
Paper 21 - SARC031: A PHASE 2 TRIAL OF SELUMETINIB AND SIROLIMUS FOR PATIENTS WITH UNRESECTABLE OR METASTATIC MALIGNANT PERIPHERAL NERVE SHEATH TUMORS
John Shern
Favorite
Shetty, Nitin
Tata Memorial Centre
Paper 79 - EVALUATION OF METRONOMIC THERAPY AS A LOW-COST, SUSTAINABLE STANDARD OF CARE OPTION IN DESMOID FIBROMATOSIS: REAL WORLD DATA FROM A TERTEARY CARE CENTRE IN INDIA
Nitin Shetty
Favorite
Shirai, Ryota
Department of Pediatrics, University of Colorado
Paper 57 - HIGH-THROUGHPUT DRUG SCREENING IDENTIFIES GSK3B INHIBITION AS A THERAPEUTIC TARGET TO ENHANCE ALLOGENEIC NK CELL CYTOTOXICITY IN EWING SARCOMA
Ryota Shirai
Favorite
Shlien, Adam
Research Institute, The Hospital for Sick Children
Session 2: Sarcoma Biology & 'omics
Location: VCC, East Exhibition Hall A
Adam Shlien
Favorite
Paper 11 - SIGNATURES OF COPY NUMBER ALTERATIONS IN HUMAN CANCER
Adam Shlien
Favorite
Paper 12 - THE DEVELOPMENT OF A MULTISCALE TRANSCRIPTIONAL ATLAS OF SARCOMA
Adam Shlien
Favorite
Shukla, Neerav
Department of Pediatrics, Memorial Sloan Kettering Cancer Center
Paper 25 - DISCONTINUATION OF LAROTRECTINIB PRIOR TO DISEASE PROGRESSION IN PEDIATRIC SARCOMA: UPDATED ANALYSIS FROM SCOUT TRIAL
Neerav Shukla
Favorite
Shuster, Dale
Daiichi Sankyo, Inc, Basking Ridge, NJ, USA
Paper 47 - LONG-TERM EFFICACY AND SAFETY OF PEXIDARTINIB IN PATIENTS WITH TENOSYNOVIAL GIANT CELL TUMOR: RESULTS FROM THE PHASE 3 ENLIVEN STUDY
Dale Shuster
Favorite
Sicklick, Jason
UC San Diego Health
Paper 01 - CREATION AND IMPLEMENTATION OF A MONTHLY INTERNATIONAL TUMOR BOARD: EXPERIENCE OF THE TRANSATLANTIC AUSTRALASIAN RETROPERITONEAL SARCOMA WORKING GROUP (TARPSWG)
Jason Sicklick
Favorite
Sieverling, Lina
Division of Translational Medical Oncology, National Center for Tumor Diseases (NCT) Heidelberg and German Cancer Research Center (DKFZ)
Paper 10 - GENOMIC AND TRANSCRIPTOMIC FEATURES OF ACTIVATED TELOMERE MAINTENANCE MECHANISMS IN SARCOMA
Lina Sieverling
Favorite
Simmons, Christine
BC Cancer
Paper 03 - ASSESSING THE VALUE OF A NATIONAL SARCOMA GOOGLE GROUP FOR CANADIAN MEDICAL ONCOLOGISTS IN THE MANAGEMENT OF SARCOMA
Christine Simmons
Favorite
Singer, Samuel
Memorial Sloan Kettering Cancer Center
Paper 08 - DEFICIENCY OF ATRX RESHAPES CHROMATIN LANDSCAPES AND LEADS TO ABERRANT LINEAGE COMMITMENT IN MESENCHYMAL PROGENITORS AND ALTERED INFLAMMATORY PATHWAYS IN UNDIFFERENTIATED PLEOMORPHIC SARCOMA
Samuel Singer
Favorite
Singh, Arun
University of California at Los Angeles
Paper 43 - A NOVEL PROGNOSTICATION SYSTEM FOR PATIENTS WITH HIGH-RISK KIT EXON 9-MUTATED GASTROINTESTINAL STROMAL TUMOUR RECEIVING ADJUVANT IMATINIB
Arun Singh
Favorite
Singh, Reena
Medical College of Wisconsin
Paper 37 - ELEVATED CIRCULATING TNF-A AND IFNΓ MAY BE CORRELATED WITH POST-RADIATION FIBROSIS IN SOFT TISSUE SARCOMAS
Reena Singh
Favorite
Siontis, Brittany
Mayo Clinic
Paper 18 - PHASE II MULTI-CENTER TRIAL OF TRABECTEDIN IN COMBINATION WITH OLAPARIB IN ADVANCED UNRESECTABLE OR METASTATIC SARCOMA
Brittany Siontis
Favorite
Paper 22 - P10015/SARC033: A PHASE 2 TRIAL OF TRAMETINIB IN PATIENTS WITH ADVANCED EPITHELIOID HEMANGIOENDOTHELIOMA
Brittany Siontis
Favorite
Paper 41 - TREATMENT OUTCOMES OF EXTRASKELETAL EWING SARCOMA: SHOULD RADIOTHERAPY BE COMBINED WITH CHEMOTHERAPY AND SURGERY IN ALL PATIENTS?
Brittany Siontis
Favorite
Siu, Lillian
Princess Margaret Cancer Centre, University Health Network
Paper 55 - INTRATUMORAL INT230-6 (CISPLATIN, VINBLASTINE, SHAO) ALONE OR WITH IPILIMUMAB PROLONGED SURVIVAL WITH FAVORABLE SAFETY IN ADULTS WITH REFRACTORY SARCOMAS (NCT 03058289)
Lillian Siu
Favorite
Skoczylas, Jacek
TARPSWG
Paper 01 - CREATION AND IMPLEMENTATION OF A MONTHLY INTERNATIONAL TUMOR BOARD: EXPERIENCE OF THE TRANSATLANTIC AUSTRALASIAN RETROPERITONEAL SARCOMA WORKING GROUP (TARPSWG)
Jacek Skoczylas
Favorite
Slawaska-Eng, David
McMaster University
Paper 73 - RISK FACTORS FOR ALL-CAUSE EARLY RE-OPERATIONS IN PATIENTS UNDERGOING TUMOR RESECTION AND ENDOPROSTHETIC RECONSTRUCTION: A SECONDARY ANALYSIS FROM THE PARITY TRIAL
David Slawaska-Eng
Favorite
Sleijfer, Stefan
Erasmus Medical Center Rotterdam
Paper 77 - ACTIVE SURVEILLANCE IN PATIENTS WITH DESMOID-TYPE FIBROMATOSIS: A COMBINED ANALYSIS OF TWO PROSPECTIVE OBSERVATIONAL STUDIES
Stefan Sleijfer
Favorite
Slotkin, Emily
Memorial Sloan Kettering Cancer Center
Paper 92 - LONG-TERM OUTCOMES IN CHILDREN, ADOLESCENTS, AND YOUNG ADULTS WITH LOCALIZED EWING SARCOMA TREATED WITH IFOSFAMIDE DOSE-INTENSIFICATION
Emily Slotkin
Favorite
SMADJA, Jeremy
Institut Curie - Paris, FRANCE
Paper 34 - PERCUTANEOUS UTERINE NEEDLE BIOPSY WITH MICROSCOPIC AND ARRAY-CGH ANALYSES IN PATIENTS WITH SUSPICIOUS MYOMETRIAL TUMORS ON MRI: A PROSPECTIVE STUDY
Jeremy SMADJA
Favorite
Smith, Henry
Institute of Cancer Research
Paper 59 - COMBINATION OF ONCOLYTIC VIROTHERAPY WITH ISOLATED LIMB PERFUSION IN ADVANCED UNRESECTABLE EXTREMITY SARCOMA RESULTS IN IMMUNE ACTIVATION: RESULTS OF A PHASE I/II CLINICAL TRIAL
Henry Smith
Favorite
Smith, L. Mary
SpringWorks Therapeutics
Paper 80 - DEFI: A PHASE 3, RANDOMIZED, DOUBLE-BLIND TRIAL OF NIROGACESTAT VERSUS PLACEBO FOR PROGRESSING DESMOID TUMORS/AGGRESSIVE FIBROMATOSIS
L. Mary Smith
Favorite
Smith, Myles
Sarcoma Unit, Royal Marsden Hospital
Paper 59 - COMBINATION OF ONCOLYTIC VIROTHERAPY WITH ISOLATED LIMB PERFUSION IN ADVANCED UNRESECTABLE EXTREMITY SARCOMA RESULTS IN IMMUNE ACTIVATION: RESULTS OF A PHASE I/II CLINICAL TRIAL
Myles Smith
Favorite
Paper 86 - POST-IRRADIATION SARCOMAS: INCREASE IN REFERRALS AND IMPROVED SURVIVAL AT AN EXPERT SARCOMA REFERRAL CENTRE OVER THREE DECADES
Myles Smith
Favorite
Snow, Hayden
Peter MacCallum Cancer Centre
Paper 71 - SUBTYPE-RELATED RESPONSE TO ISOLATED LIMB PERFUSION IN SOFT TISSUE SARCOMAS
Hayden Snow
Favorite
Snuderl, Matija
Department of Pathology, New York University Langone Health, Perlutter Cancer Center
Paper 07 - CLINICAL AND GENOMIC PROGNOSTIC FACTORS IN MALIGNANT PERIPHERAL NERVE SHEATH TUMORS: INSIGHTS GAINED THROUGH THE GENOMICS OF MPNST CONSORTIUM
Matija Snuderl
Favorite
Somaiah, Neeta
The University of Texas MD Anderson Cancer Center
Session 9: Immunology & Immunotherapy
Location: VCC, East Exhibition Hall A
Neeta Somaiah
Favorite
Paper 09 - DEFINING DIFFERENTIATION STATES IN WELL-DIFFERENTIATED AND DE-DIFFERENTIATED LIPOSARCOMA
Neeta Somaiah
Favorite
Paper 89 - A PHASE 1/2 TRIAL OF GEMCITABINE, DOCETAXEL, AND HYDROXYCHLOROQUINE IN ADVANCED/METASTATIC OSTEOSARCOMA: RESULTS OF PHASE 1
Neeta Somaiah
Favorite
Sorensen, Poul
University of British Columbia
Herman Suit Lecture: Sarcoma Translocations: Dangerous Liaisons, Or Portals To Improved Diagnostics, New Biology, And Targeted Therapeutics
Location: VCC, East Exhibition Hall A
Poul Sorensen
Favorite
Spargo, Sarah
Indiana University Melvin and Bren Simon Cancer Center
Paper 60 - REAL-WORLD EXPERIENCE OF THE EFFICACY, TOLERABILITY, AND PREDICTORS OF RESPONSE TO IPILIMUMAB PLUS NIVOLUMAB IN ADVANCED NON-TRANSLOCATED SARCOMAS
Sarah Spargo
Favorite
Spierenburg, Geert
Leiden University Medical Center
Paper 49 - INTERACTIONS IN CSF1-DRIVEN TENOSYNOVIAL GIANT CELL TUMORS
Geert Spierenburg
Favorite
Srinivas, Sujay
Tata Memorial Centre
Paper 79 - EVALUATION OF METRONOMIC THERAPY AS A LOW-COST, SUSTAINABLE STANDARD OF CARE OPTION IN DESMOID FIBROMATOSIS: REAL WORLD DATA FROM A TERTEARY CARE CENTRE IN INDIA
Sujay Srinivas
Favorite
Stacchiotti, Silvia
Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
Mentorship Session 6: Wellness/Work Life Balance
Silvia Stacchiotti
Favorite
Paper 47 - LONG-TERM EFFICACY AND SAFETY OF PEXIDARTINIB IN PATIENTS WITH TENOSYNOVIAL GIANT CELL TUMOR: RESULTS FROM THE PHASE 3 ENLIVEN STUDY
Silvia Stacchiotti
Favorite
Paper 63 - DO EARLY RECURRENT PRIMARY RETROPERITONEAL SARCOMA (RPS) HAVE SIMILAR SURVIVAL TO INOPERABLE RPS: WAS SURGERY WORTHY?
Silvia Stacchiotti
Favorite
Paper 65 - IDENTIFICATION OF A GENOMIC SIGNATURE THAT IMPROVES THE PERFORMANCE OF THE SARCULATOR NOMOGRAM FOR PATIENTS WITH PRIMARY RETROPERITONEAL SARCOMA
Silvia Stacchiotti
Favorite
Paper 77 - ACTIVE SURVEILLANCE IN PATIENTS WITH DESMOID-TYPE FIBROMATOSIS: A COMBINED ANALYSIS OF TWO PROSPECTIVE OBSERVATIONAL STUDIES
Silvia Stacchiotti
Favorite
Stas, Marguerite
Universitair Ziekenhuis Leuven
Paper 71 - SUBTYPE-RELATED RESPONSE TO ISOLATED LIMB PERFUSION IN SOFT TISSUE SARCOMAS
Marguerite Stas
Favorite
Steeghs, Neeltje
The Netherlands Cancer Institute
Paper 43 - A NOVEL PROGNOSTICATION SYSTEM FOR PATIENTS WITH HIGH-RISK KIT EXON 9-MUTATED GASTROINTESTINAL STROMAL TUMOUR RECEIVING ADJUVANT IMATINIB
Neeltje Steeghs
Favorite
Steele, Christopher D
Research Department of Pathology, University College London Cancer Institute
Paper 07 - CLINICAL AND GENOMIC PROGNOSTIC FACTORS IN MALIGNANT PERIPHERAL NERVE SHEATH TUMORS: INSIGHTS GAINED THROUGH THE GENOMICS OF MPNST CONSORTIUM
Christopher D Steele
Favorite
Paper 11 - SIGNATURES OF COPY NUMBER ALTERATIONS IN HUMAN CANCER
Christopher D Steele
Favorite
Steffner, Robert
Stanford University
Paper 49 - INTERACTIONS IN CSF1-DRIVEN TENOSYNOVIAL GIANT CELL TUMORS
Robert Steffner
Favorite
Stethen, Taylor
Indiana University Melvin and Bren Simon Cancer Center
Paper 60 - REAL-WORLD EXPERIENCE OF THE EFFICACY, TOLERABILITY, AND PREDICTORS OF RESPONSE TO IPILIMUMAB PLUS NIVOLUMAB IN ADVANCED NON-TRANSLOCATED SARCOMAS
Taylor Stethen
Favorite
Steuer, Conor
Winship Cancer Institute, Emory University School of Medicine
Paper 23 - UPDATED EFFICACY AND SAFETY OF ENTRECTINIB IN PATIENTS WITH NTRK FUSION-POSITIVE SARCOMAS
Conor Steuer
Favorite
Storhaug, Gudveig
Oslo University Hospital
Paper 53 - THERE’S NO PLACE LIKE HOME. TREATING ADOLESCENTS AND YOUNG ADULTS WITH SARCOMA AT HOME
Gudveig Storhaug
Favorite
Strauss, Dirk
Sarcoma Unit, The Royal Marsden Hospital NHS Foundation Trust
Paper 01 - CREATION AND IMPLEMENTATION OF A MONTHLY INTERNATIONAL TUMOR BOARD: EXPERIENCE OF THE TRANSATLANTIC AUSTRALASIAN RETROPERITONEAL SARCOMA WORKING GROUP (TARPSWG)
Dirk Strauss
Favorite
Paper 64 - PRIMARY RETROPERITONEAL SARCOMA: VARIABILITY OF RESECTABILITY AND TREATMENT ALLOCATION DURING MULTIDISCIPLINARY TEAM MEETING ASSESSMENTS IN ENGLAND
Dirk Strauss
Favorite
Paper 86 - POST-IRRADIATION SARCOMAS: INCREASE IN REFERRALS AND IMPROVED SURVIVAL AT AN EXPERT SARCOMA REFERRAL CENTRE OVER THREE DECADES
Dirk Strauss
Favorite
Strauss, Sandra
University College, London
Paper 51 - PAIRWISE COMPARISONS OF THE FOUR CHEMOTHERAPY REGIMENS INITIALLY INCLUDED IN THE REECUR TRIAL FOR THE TREATMENT OF PRIMARY REFRACTORY AND RECURRENT EWING SARCOMA (RR-ES)
Sandra Strauss
Favorite
Strauss, Sandra
Sarcoma Department, University College Hospital, London
Paper 52 - AN AMBULATORY CARE APPROACH TO DELIVERY OF CHEMOTHERAPY FOR TEENAGE YOUNG ADULT (TYA) SARCOMA: EVALUATION OF ITS UTILITY AND BENEFIT
Sandra Strauss
Favorite
Subbiah, Vivek
The University of Texas MD Anderson Cancer Center
Paper 94 - GENOMIC ALTERATIONS OF DNA DAMAGE REPAIR PATHWAYS IN CHORDOMA: AN ANALYSIS FROM THE AACR-GENIE DATABASE
Vivek Subbiah
Favorite
Sulciner, Megan
Brigham and Women's Hospital/Harvard Medical School
Paper 67 - CONVERSION OF RETROPERITONEAL WELL-DIFFERENTIATED TO DEDIFFERENTIATED LIPOSARCOMA: A TARPSWG NATURAL HISTORY STUDY
Megan Sulciner
Favorite
Sundby, Taylor
National Cancer Institute
Paper 07 - CLINICAL AND GENOMIC PROGNOSTIC FACTORS IN MALIGNANT PERIPHERAL NERVE SHEATH TUMORS: INSIGHTS GAINED THROUGH THE GENOMICS OF MPNST CONSORTIUM
Taylor Sundby
Favorite
Paper 21 - SARC031: A PHASE 2 TRIAL OF SELUMETINIB AND SIROLIMUS FOR PATIENTS WITH UNRESECTABLE OR METASTATIC MALIGNANT PERIPHERAL NERVE SHEATH TUMORS
Taylor Sundby
Favorite
Surdez, Didier
Institut Curie Research Center
Paper 90 - STAGING OF NEWLY DIAGNOSED EWING SARCOMA: RESULTS OF BONE MARROW ASPIRATION AND BIOPSY VERSUS (18) FDG-PET SCAN FOR BONE MARROW INVOLVEMENT
Didier Surdez
Favorite
Sutton, Thomas
Oregon Health and Science University
Paper 43 - A NOVEL PROGNOSTICATION SYSTEM FOR PATIENTS WITH HIGH-RISK KIT EXON 9-MUTATED GASTROINTESTINAL STROMAL TUMOUR RECEIVING ADJUVANT IMATINIB
Thomas Sutton
Favorite
Swallow, Carol
University of Toronto
Paper 01 - CREATION AND IMPLEMENTATION OF A MONTHLY INTERNATIONAL TUMOR BOARD: EXPERIENCE OF THE TRANSATLANTIC AUSTRALASIAN RETROPERITONEAL SARCOMA WORKING GROUP (TARPSWG)
Carol Swallow
Favorite
Paper 62 - WHY DO PATIENTS WITH NON-METASTATIC PRIMARY RETROPERITONEAL SARCOMA NOT UNDERGO RESECTION? A RETROSPECTIVE SERIES OF 276 PATIENTS TREATED IN TWO SPECIALIZED SARCOMA CENTERS
Carol Swallow
Favorite
Paper 67 - CONVERSION OF RETROPERITONEAL WELL-DIFFERENTIATED TO DEDIFFERENTIATED LIPOSARCOMA: A TARPSWG NATURAL HISTORY STUDY
Carol Swallow
Favorite
Szymanski, Jeffrey J
Division of Cancer Biology, Department of Radiation Oncology, Washington University School of Medicine
Paper 07 - CLINICAL AND GENOMIC PROGNOSTIC FACTORS IN MALIGNANT PERIPHERAL NERVE SHEATH TUMORS: INSIGHTS GAINED THROUGH THE GENOMICS OF MPNST CONSORTIUM
Jeffrey J Szymanski
Favorite
Back to Top
